Skip to content

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Aju.News

  • Korea
  • World
  • Technology
  • Business
  • Sports
  • Entertainment
  • Health

Novartis

Korea’s first CAR-T company’QROCELL’ goes beyond Novartis and counts IPO

Korea’s first CAR-T company’QROCELL’ goes beyond Novartis and counts IPO

Lee Jun-yup, Professor of Seoul Asan Hospital, selected as’Novatis Innovation Research Support Program’

Lee Jun-yup, Professor of Seoul Asan Hospital, selected as’Novatis Innovation Research Support Program’

Seoul Asan Hospital Professor Jun-Yeop Lee, Selected as a Novartis Global Innovation Research Support Program

Seoul Asan Hospital Professor Jun-Yeop Lee, Selected as a Novartis Global Innovation Research Support Program

Prof. Joon-Yup Lee selected as a Novartis Innovation Research Support Program

Prof. Joon-Yup Lee selected as a Novartis Innovation Research Support Program

Ministry of Food and Drug Safety licensed Novartis’ CAR-T cell treatment’No. 1 advanced biopharmaceutical’

Ministry of Food and Drug Safety licensed Novartis’ CAR-T cell treatment’No. 1 advanced biopharmaceutical’

Novartis Korea acquires domestic license for CAR-T treatment Kimliha

Novartis Korea acquires domestic license for CAR-T treatment Kimliha

MEDI:GATE NEWS Novartis Korea, approved CAR-T treatment Kimria in Korea…  The first high-tech biopharmaceutical treatment was born

MEDI:GATE NEWS Novartis Korea, approved CAR-T treatment Kimria in Korea… The first high-tech biopharmaceutical treatment was born

Korea Food and Drug Administration, Novartis CAR-T anticancer drug’Kimria’ approved in Korea

Korea Food and Drug Administration, Novartis CAR-T anticancer drug’Kimria’ approved in Korea

Novartis anticancer drug’Kimria’ approved for the first high-tech biopharmaceutical in Korea

Novartis anticancer drug’Kimria’ approved for the first high-tech biopharmaceutical in Korea

CAR-T anticancer drug Novartis Kimria, Cheomba Law No. 1 drug approved in Korea

CAR-T anticancer drug Novartis Kimria, Cheomba Law No. 1 drug approved in Korea

footer

  • Contact Us
  • Sitemap
  • News-Sitemap
© 2025 Aju.News/en